Detalhe da pesquisa
1.
Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation.
Proc Natl Acad Sci U S A
; 121(22): e2321600121, 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771881
2.
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents.
Cancer Immunol Immunother
; 72(9): 3029-3043, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310433
3.
NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-E.
Immunology
; 166(4): 507-521, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35596615
4.
PD-1 blocking antibodies moonlighting as killers.
Eur J Immunol
; 51(6): 1361-1364, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33954999
5.
4-1BB costimulation promotes bystander activation of human CD8 T cells.
Eur J Immunol
; 51(3): 721-733, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33180337
6.
The soluble cytoplasmic tail of CD45 regulates T-cell activation via TLR4 signaling.
Eur J Immunol
; 51(12): 3176-3185, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34626426
7.
Saturated very long-chain fatty acids regulate macrophage plasticity and invasiveness.
J Neuroinflammation
; 19(1): 305, 2022 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528616
8.
Design, synthesis and biological evaluation of PD-1 derived peptides as inhibitors of PD-1/PD-L1 complex formation for cancer therapy.
Bioorg Chem
; 128: 106047, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963023
9.
Targeting the HVEM protein using a fragment of glycoprotein D to inhibit formation of the BTLA/HVEM complex.
Bioorg Chem
; 122: 105748, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325694
10.
Fragments of gD Protein as Inhibitors of BTLA/HVEM Complex Formation-Design, Synthesis, and Cellular Studies.
Int J Mol Sci
; 21(22)2020 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33238640
11.
Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancer.
Transl Oncol
; 42: 101892, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359715
12.
BTLA-derived peptides as inhibitors of BTLA/HVEM complex formation - design, synthesis and biological evaluation.
Biomed Pharmacother
; 165: 115161, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37473684
13.
Interrogating ligand-receptor interactions using highly sensitive cellular biosensors.
Nat Commun
; 14(1): 7804, 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016944
14.
BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM.
Front Immunol
; 13: 956694, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36081508
15.
TLR4/CD14/MD2 Revealed as the Limited Toll-like Receptor Complex for Chlamydia trachomatis-Induced NF-κB Signaling.
Microorganisms
; 10(12)2022 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36557742
16.
Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer.
Cancers (Basel)
; 14(22)2022 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428769
17.
A Highly Sensitive Cell-Based TLR Reporter Platform for the Specific Detection of Bacterial TLR Ligands.
Front Immunol
; 12: 817604, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35087538
18.
A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors.
Front Immunol
; 11: 895, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32528470
19.
Publisher Correction: Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor.
Sci Rep
; 9(1): 16382, 2019 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31690814
20.
Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor.
Sci Rep
; 9(1): 7426, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31092850